- Home
- OSUR vs PRQR Comparison
OSUR vs PRQR Comparison
Compare OSUR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- PRQR
- Stock Information
- Founded
- OSUR 2000
- PRQR 2012
- Country
- OSUR United States
- PRQR Netherlands
- Employees
- OSUR N/A
- PRQR N/A
- Industry
- OSUR Medical/Dental Instruments
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- PRQR Health Care
- Exchange
- OSUR Nasdaq
- PRQR Nasdaq
- Market Cap
- OSUR 223.0M
- PRQR 179.1M
- IPO Year
- OSUR 1986
- PRQR 2014
- Fundamental
- Price
- OSUR $3.10
- PRQR $2.35
- Analyst Decision
- OSUR Hold
- PRQR Strong Buy
- Analyst Count
- OSUR 1
- PRQR 8
- Target Price
- OSUR $3.00
- PRQR $8.88
- AVG Volume (30 Days)
- OSUR 750.0K
- PRQR 357.1K
- Earning Date
- OSUR 08-05-2025
- PRQR 08-07-2025
- Dividend Yield
- OSUR N/A
- PRQR N/A
- EPS Growth
- OSUR N/A
- PRQR N/A
- EPS
- OSUR N/A
- PRQR N/A
- Revenue
- OSUR $161,626,000.00
- PRQR $21,212,711.00
- Revenue This Year
- OSUR N/A
- PRQR N/A
- Revenue Next Year
- OSUR $6.20
- PRQR N/A
- P/E Ratio
- OSUR N/A
- PRQR N/A
- Revenue Growth
- OSUR N/A
- PRQR 85.91
- 52 Week Low
- OSUR $2.36
- PRQR $1.07
- 52 Week High
- OSUR $4.92
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- OSUR 59.68
- PRQR 66.90
- Support Level
- OSUR $3.00
- PRQR $2.10
- Resistance Level
- OSUR $3.13
- PRQR $2.18
- Average True Range (ATR)
- OSUR 0.12
- PRQR 0.13
- MACD
- OSUR 0.00
- PRQR 0.01
- Stochastic Oscillator
- OSUR 80.65
- PRQR 56.92
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.